Inflammatory Breast Cancer: Treatment Over Time CME

Author Information and Disclosures

Release Date: April 30, 2008; Valid for credit through April 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Printable Handout for Your Patients
Inflammatory Breast Cancer FAQ [PDF]

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Susan G. Komen
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review diagnostic criteria, prognosis, and differential diagnosis of inflammatory breast cancer.
  2. Describe techniques, including biopsy and imaging modalities, required to establish the diagnosis of inflammatory breast cancer.
  3. Explain pathologic diagnosis of inflammatory breast cancer and most common findings with respect to hormone expression and biomarker status.
  4. Discuss multimodality treatment options for patients with inflammatory breast cancer, including surgery, radiation, and systemic therapies.
Authors and Disclosures

Massimo Cristofanilli, MD
Disclosure: Massimo Cristofanilli, MD, has disclosed that he has received honorarium from Veridex and that he owns stock in Cellexicon.


Margie Miller
Disclosure: Margie Miller has disclosed no relevant financial relationships.


Jill W. Chamberlain
Disclosure: Jill W. Chamberlain has disclosed no relevant financial relationships.


Emma Hitt, PhD
Disclosure: Emma Hitt, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.